Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GW Pharmaceuticals PLC (NASDAQ:GWPH)

125.41
BATS BZX Real-Time Price
As of 11:12am ET
 +2.86 / +2.33%
Today’s Change
92.65
Today|||52-Week Range
136.95
+12.22%
Year-to-Date

Today’s Trading

Previous close122.55
Today’s open122.82
Day’s range122.82 - 125.56
Volume3,530
Average volume (3 months)375,623
Market cap$3.1B
Data as of 11:12am ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)-65.46%
Earnings growth (this year)--
Earnings growth (next 5 years)-50.35%
Revenue growth (last year)-28.45%
P/E ratioNM
Price/Sales246.06
Price/Book8.39

Competitors

 Today’s
change
Today’s
% change
PBHPrestige Brands Hold...+0.49+1.06%
MDCOMedicines Co+1.19+4.58%
CBPOChina Biologic Produ...-1.52-1.94%
LGNDLigand Pharmaceutica...+1.30+0.96%
Data as of 11:12am ET, 12/12/2017

Financials

Last reporting dateDecember 4, 2017
EPS forecast (this quarter)-$1.81
Annual revenue (last year)$10.4M
Annual profit (last year)-$166.8M
Net profit margin-1,598.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Justin D. Gover
Chief Operating Officer &
Executive Director
Christopher John Tovey
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts